Table S3 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Table S3 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024
2. 2Table S5 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024
3. 3Table S5 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024
4. 4Table S2 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024
5. 5Table S2 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024